CareLit · DOI-Nachweis · Aktuelle Neurologie
Migraine preventive therapy with topiramate reduces the number of migraine auras: results from PROMPT, a randomised, placebo-controlled trial
DOI 10.1055/s-0028-1086729
Bibliografische Angaben
Nachweis in CareLit
Autor:innenU Reuter, A Gendolla, M Sanchez del Rio, H.C Diener, G Allais, J Pfeil, S Schwalen, B Schäuble, J van Oene
ZeitschriftAktuelle Neurologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Rationale: To evaluate topiramate efficacy for prevention of migraine aura's in addition to migraine headaches. Methods: After a 4–8-week baseline period, patients entered a 26-week open-label phase (OL); topiramate was titrated from 25 to 100mg/day in weekly 25-mg steps, and could be further adjusted (range: 50–200mg/day). Dosing was kept stable for the last 4 weeks, and patients were randomised to continue this do…
Zitieren
Zitierempfehlung
U Reuter, A Gendolla, M Sanchez del Rio, H.C Diener, G Allais, J Pfeil, S Schwalen, B Schäuble, J van Oene (2008) Migraine preventive therapy with topiramate reduces the number of migraine auras: results from PROMPT, a randomised, placebo-controlled trial. Aktuelle Neurologie (09). https://doi.org/10.1055/s-0028-1086729
Mit CareLit weiterarbeiten